Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
Sales | 372 | 0 | 0 | 0 | 0 |
Cost of Goods | 84 | N/A | N/A | N/A | N/A |
Gross Profit | 288 | N/A | N/A | N/A | N/A |
Operating Expenses | 13,250 | 4,295 | 4,989 | 5,263 | 5,239 |
Operating Income | -12,878 | -4,295 | -4,989 | -5,263 | -5,239 |
Other Income | -1,853 | -3,796 | -11,291 | -4,121 | 232 |
Pre-tax Income | -14,731 | -8,091 | -16,281 | -9,384 | -5,007 |
Net Income Continuous | -14,731 | -8,091 | -16,281 | -9,384 | -5,007 |
Net Income | $-14,731 | $-8,091 | $-16,281 | $-9,384 | $-5,007 |
EPS Basic Total Ops | -0.60 | -0.33 | -0.77 | -0.54 | -0.31 |
EPS Basic Continuous Ops | -0.60 | -0.33 | -0.77 | -0.54 | -0.31 |
EPS Diluted Total Ops | -0.60 | -0.33 | -0.77 | -0.41 | -0.31 |
EPS Diluted Continuous Ops | -0.60 | -0.33 | -0.77 | -0.56 | -0.31 |
EPS Diluted Before Non-Recurring Items | -0.53 | -0.23 | 1.08 | -0.32 | -0.31 |
EBITDA(a) | $-12,865 | $-4,285 | $-4,566 | $-5,250 | $-5,225 |